Why is the Ramsay share price smashing the ASX 200 on Monday?

Ramsay shares are off to a positive start today.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • Ramsay shares are trading higher today, up 1.49% to $78.31 at the time of writing
  • The company confirmed details of the new funding agreement arrangement for 1 January to 30 June 2022
  • Ramsay shares moved sideways up until mid-April before the company received a takeover bid

The Ramsay Health Care Ltd (ASX: RHC) share price is climbing higher into the green today.

This comes as the private hospital operator provider made an announcement to investors on the ASX.

At the time of writing, Ramsay shares are swapping hands at $78.31, up 1.49%.

In comparison, the S&P/ASX 200 Index (ASX: XJO) is giving back all its gains achieved during early morning trade. The benchmark ASX 200 is currently trading at 7,086.9 points, up just 0.17%.

A telehealth doctor at her desk.

Image source: Getty Images

What did Ramsay announce?

In its statement, Ramsay confirmed the details of funding guarantee arrangements for the period between 1 January and 30 June 2022.

Announced by the French Government on 14 May, the company said the structure of the decree was similar to prior periods. However, mental health has been excluded in the latest scheme.

While the details regarding the arrangement have not been disclosed, the previous corresponding period's decree provided a guarantee of revenue equal to the average monthly revenue earned from the government.

Pulled from the 2020 calendar year, the revenue was indexed and multiplied by the six months covered by the decree.

About the Ramsay share price

After trading fairly flat for most of 2022, the Ramsay share price suddenly rocketed to a 52-week high of $84.58 in April.

The 25% gain came after the company received a $14.8 billion takeover offer from a consortium of investors led by KKR.

The Ramsay share price is up around 22% over the past 12 months and is trading 9% higher year to date.

Based on today's price, Ramsay commands a market capitalisation of roughly $17.93 billion and has 228.88 million shares on hand.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Young businesswoman sitting in kitchen and working on laptop.
Healthcare Shares

Down 50%, why I'd invest $20,000 into CSL shares

A 50% decline in a blue-chip share can signal trouble, but not always a broken story.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

This ASX biotech stock could deliver 40%-plus returns Morgans says

This small company continues to kick goals.

Read more »

A man with his back to the camera holds his hands to his head as he looks to a jagged red line trending sharply downward.
Healthcare Shares

How high could Cochlear shares bounce back? Brokers disagree

Despite bad news on the earnings front this week, Cochlear shares could still deliver upside.

Read more »

Retired couple hugging and laughing.
Healthcare Shares

A Budget announcement has put a rocket under this ASX aged care provider's shares

A shake up in the funding model will be a boost for this company.

Read more »

An arrow crashes through the ground as a businessman watches on.
Healthcare Shares

Cochlear stock down 40%: How much has this cost ASX investors?

One day can ruin years of success...

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Healthcare Shares

What on earth's going on with Pro Medicus shares?

The quality stock is now driven heavily by expectations.

Read more »

A stressed businessman sits next to his briefcase with his head in his hands, while the ASX boards behind him show shares crashing.
52-Week Lows

CSL's collapse deepens. Why this ASX giant can't find a floor

CSL shares hit a 9-year low as new demand concerns emerge.

Read more »

A group of people in a corporate setting do a collective high five.
Healthcare Shares

Prediction: CSL shares could surpass $265 in 2026

CSL shares are tumbling again on Wednesday. Here's what it'll take for the price to take a u-turn.

Read more »